
Shire was founded in 1986 in the UK, initially focusing on developing products for the ADHD market. Over the years, the company expanded its portfolio through organic growth and strategic acquisitions, becoming a leading player in the biotechnology field. In 2018, Shire was acquired by Takeda Pharmaceutical Company, further enhancing its capabilities and reach.